Dry eye disease leaves many adults staring at a screen or reading a book while their eyes burn. For people aged 30 and older with a confirmed diagnosis, a new treatment called acoltremon offered real relief. In two large studies involving nearly 930 patients, this medication helped eyes produce more tears and feel less pain.
The treatment was used twice daily for up to 90 days. By day 14, more than 42 percent of patients using acoltremon saw their tear production jump by 10 millimeters or more. This was a big improvement compared to those using a vehicle, which had no active medicine. By day 28, patients reported less overall eye discomfort. These benefits continued through day 90.
The medication also reduced staining on the eye surface, a sign of irritation. The only side effect reported was mild burning or stinging where the drops were placed. This happened in a small number of people and was the only issue that occurred more than 2.5 percent of the time. No serious problems were found during the trials.
While these results are promising, remember that this data comes from specific clinical trials. The study did not report how long these effects last after stopping the drops. Always talk to a doctor before starting any new eye medication.
